Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Fastenal Stock Pulls Back in October—Is It Time to Buy FAST?

Fastenal had a solid quarter despite falling short of analysts' estimates, growing at a double-digit pace and widening its margin.

MarketBeat · Oct 14, 2025

Why Congress Is Buying Intuitive Surgical Ahead of Earnings

Intuitive Surgical has attracted recent congressional buying ahead of its next quarterly earnings results, implying a new potential bull run

MarketBeat · Oct 14, 2025

FICO’s Big Dip Could Be the Best Buying Chance of the Year

Why is FICO stock down and is it a buy? Despite Equifax’s new product, FICO still holds 85–90% of the mortgage market, making this dip a buying opportunity.

MarketBeat · Oct 13, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

D-Wave: Reevaluating the Short Seller’s Case After the Downgrade

D-Wave Quantum is one of the most-hyped stocks on the market, but how does the short seller's case against a firm with a 3,200% return in the last year hold up?

MarketBeat · Oct 13, 2025

Datavault: A Speculative AI Play, But Beware of Volatility

Datavault's technology is supported by deals with companies like IBM, which is committing millions of resources to support platform expansion.

MarketBeat · Oct 13, 2025

Traders Are Piling Into Suncor Call Options—Should You?

A 2,998% surge in SU call options signals major confidence. With rising EPS and limited tariff risk, Suncor stock could be primed for a breakout.

MarketBeat · Oct 13, 2025

Delta Air Lines Stock Looks Ready to Fly to New Highs

Delta Air Lines is on track to increase its dividend robustly and for its share price to reach new highs. The industry leader is growing, outperforming in Q3.

MarketBeat · Oct 13, 2025

Read news from The Economist, FT, and more,
with one subscription

2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk

Absci's AI drug development platform is compelling, and its pipeline is promising...but can the company overcome execution hurdles to live up to analyst hype?

MarketBeat · Oct 13, 2025

Applied Digital’s Shorts Got Squeezed—Now What?

Applied Digital is well-positioned to benefit from ballooning hyperscaler demand and the AI revolution. Analysts are bullish, but a price correction is imminent

MarketBeat · Oct 13, 2025

Levi Strauss Stock Set to Reach New Highs in 2026

Levi Strauss's dividend is reliable and expected to grow, with shareholder value compounded by share repurchases and organic business growth.

MarketBeat · Oct 13, 2025

Alphabet: The AI Powerhouse Driving Markets Into 2026

The launch of Gemini Enterprise marks Google’s push to embed AI across enterprise workflows, integrating its full-stack infrastructure from Cloud to Workspace.

MarketBeat · Oct 13, 2025

These 3 Stocks Just Got Upgraded—and Could Keep Climbing

These companies have all seen notable interest from analysts that have recently upgraded their ratings, a potential signal of gains ahead.

MarketBeat · Oct 13, 2025

Is the Reddit-ChatGPT Love Affair Over?

With ChatGPT relying less on Reddit, shares of RDDT plummeted last week. But the company’s licensing agreements and core ad business should continue to produce.

MarketBeat · Oct 13, 2025

3 Copper Stocks Ready to Shine in the Next Metal Supercycle

Copper prices are climbing as demand outpaces supply. Here are three top copper stocks and an ETF poised to benefit from the metal’s long-term bull market

MarketBeat · Oct 13, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat · Oct 12, 2025

Microsoft 365 Premium Marks the Next Phase of AI Monetization

Microsoft 365 Premium bundles Copilot AI across its productivity suite, signaling a new phase of AI monetization and recurring revenue growth for investors

MarketBeat · Oct 12, 2025

Could Target’s Week of Discounts Come Full Circle for Investors?

Target’s Circle Week may boost stock upside through deeper discounts and new memberships, helping TGT rebound from lows and drive long-term growth.

MarketBeat · Oct 12, 2025

3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings

Shares of Sprouts Farmers Market have sold off in recent months, but analysts, and the chart, say the pullback is overdone.

MarketBeat · Oct 11, 2025

Bassett Furniture: Buy Now, Sit Back, and Collect Dividends

Furniture companies like Bassett Furniture Industries are well-positioned to pay high-yielding dividends until the housing market recovers.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat · Oct 11, 2025

AST SpaceMobile's Big Win: Shares Soar on New Deal With Verizon

AST SpaceMobile's 2025 return just surged past 300%. With its latest Verizon deal, the firm has just added another huge telecom customer to its rolodex.

MarketBeat · Oct 11, 2025

Catch the Next Bitcoin Rally With These 3 ETFs

Bitcoin is on the rise again, and now you don't need to own tokens to ride the rally. Consider these 3 Bitcoin ETFs to add crypto exposure to your portfolio.

MarketBeat · Oct 11, 2025

MarketBeat Week in Review – 10/06 - 10/10

Investors are eagerly awaiting the start of earnings season for market direction, as the continued government shutdown is creating a lack of economic data

MarketBeat · Oct 10, 2025

3 Heavily Shorted Stocks That Could Pop on Rate Cuts

ETSY, SOUN, and SMR stocks are heavily shorted but rate cuts could trigger rallies by lowering borrowing costs and improving investor sentiment across sectors.

MarketBeat · Oct 10, 2025

Broadcom Gets Second $420 Target as CPO Win Boosts Outlook

Broadcom shares are taking a breather after hitting a record high. However, one Wall Street analyst just matched the firm's highest price target ever.

MarketBeat · Oct 10, 2025

PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can

PepsiCo's 4% dividend yield won't last much longer, as Q3 results affirm its long-term trajectory, indicating a stock price rebound can begin soon.

MarketBeat · Oct 10, 2025

Bargain Alert: DraftKings Is the Most Oversold It’s Ever Been

DraftKings’ RSI just hit an all-time low below 15. With analysts bullish and big buyers already starting to snap up shares, the selloff looks overdone.

1 … 156 157 158 159

Coverage From

MarketBeat

People

Gabriel OsorioMazilli

50 stories

Jordan Chussler

33 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.